GM-CSF Signaling Abnormalities in Chronic Myelomonocytic Leukemia
Eric Padron(Moffitt Cancer Center), Pearlie K. Epling‐Burnette(AbbVie (United States)), Alan F. List(TE Laboratories (Ireland)), Jeffrey S. Painter(University of South Florida), Jessica M. McDaniel(University of South Florida), Mark Baer, Adam W. Mailloux(University of South Florida), Christopher Bebbington(Curtin University), Rami S. Komrokji(Moffitt Cancer Center)
Cited by 3
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
|Journal of Clinical Oncology|2009|963
Efficacy of Lenalidomide in Myelodysplastic Syndromes
|New England Journal of Medicine|2005|874
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739
Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product
|The Journal of Immunology|1998|546